HUSSMAN STRATEGIC ADVISORS, INC. - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 268 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
HUSSMAN STRATEGIC ADVISORS, INC. ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$682,500
-12.1%
42,0000.0%0.19%
+3.9%
Q1 2024$776,580
-40.9%
42,0000.0%0.18%
-39.5%
Q4 2023$1,315,020
+50.2%
42,0000.0%0.30%
+79.0%
Q3 2023$875,280
-41.1%
42,000
-32.3%
0.17%
-38.8%
Q2 2023$1,484,900
-15.2%
62,000
-33.3%
0.27%
-0.7%
Q1 2023$1,750,26093,0000.28%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2024
NameSharesValueWeighting ↓
Baker Brothers Advisors 25,819,768$887,684,0007.26%
Avoro Capital Advisors LLC 1,630,000$56,039,0007.16%
ACUTA CAPITAL PARTNERS, LLC 572,756$19,691,0004.67%
HWG Holdings LP 100,994$3,472,0004.38%
HARVEY CAPITAL MANAGEMENT INC 230,350$7,919,0003.56%
SECTORAL ASSET MANAGEMENT INC 671,113$23,073,0002.70%
Palo Alto Investors LP 1,590,430$54,679,0002.58%
Ghost Tree Capital, LLC 350,000$12,033,0002.24%
GARRISON BRADFORD & ASSOCIATES INC 72,550$2,494,0002.20%
EMORY UNIVERSITY 56,135$1,930,0001.82%
View complete list of ACADIA PHARMACEUTICALS INC shareholders